EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.
Bokemeyer
C
C
Universitaetsklinikum Tuebingen, Medizinische Klinik Abteilung II, Otfried-Mueller St 10, D-72076 Tuebingen, Germany. carsten.bokemeyer@med.uni-tuebingen.de
Aapro
M S
MS
Courdi
A
A
Foubert
J
J
Link
H
H
Osterborg
A
A
Repetto
L
L
Soubeyran
P
P
D000740:Anemia / Q000209:etiology / Q000517:prevention & control*; D016026:Bone Marrow Transplantation; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D004921:Erythropoietin / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D006973:Hypertension / Q000209:etiology; D009369:Neoplasms / Q000150:complications*; D011788:Quality of Life; D016019:Survival Analysis; D013923:Thromboembolism / Q000209:etiology
D004921:Erythropoietin